Gilead Sciences Inc buy krebskrebs
Start price
03.05.20
/
50%
€77.59
Target price
04.11.21
€80.00
Performance (%)
-25.71%
End price
05.11.21
€57.64
Summary
This prediction ended on 05.11.21 with a price of €57.64. The price of Gilead Sciences Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.71%. Dividends of €3.51 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -0.800% | -0.800% | -6.719% | 9.921% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by krebskrebs for this prediction
In the thread Gilead Sciences Inc diskutieren
Buy mit Kursziel 80,0
In the thread Trading Gilead Sciences Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten